Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the seventh of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the seventh of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the sixth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the sixth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fifth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fifth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
In this video, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fourth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
In this video, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fourth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the third of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the third of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the second of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the second of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the first of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the first of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the seventh of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the seventh of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the sixth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the sixth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fifth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fifth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
In this video, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fourth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
In this video, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the fourth of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the third of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the third of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the second of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the second of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the first of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
Psych Congress Steering Committee member Rakesh Jain, MD, MPH, discusses the first of 7 habits which clinicians can develop to be highly effective at treating anxiety disorders.
James Greenblatt, MD, discusses where lifestyle, nutritional, and functional medicine strategies may help address gaps in conventional psychiatric care.
James Greenblatt, MD, discusses where lifestyle, nutritional, and functional medicine strategies may help address gaps in conventional psychiatric care.
Craig Chepke, MD, DFAPA; Kevin Williams, MS, MPAS, PA-C
Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C, discuss how clinicians can align major depressive disorder (MDD) treatment goals with patients’ lived experience of anhedonia.
Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C, discuss how clinicians can align major depressive disorder (MDD) treatment goals with patients’ lived experience of anhedonia.
In this conversation with PCN, Arwen Podesta, MD, DFAPA, DFASAM, discusses how medication-assisted therapy (MAT) may improve patient outcomes in alcohol use disorder (AUD).
In this conversation with PCN, Arwen Podesta, MD, DFAPA, DFASAM, discusses how medication-assisted therapy (MAT) may improve patient outcomes in alcohol use disorder (AUD).
Rakesh Jain, MD, MPH, Co-Chair, Psych Congress discusses why sleep complaints in psychiatric practice warrant direct evaluation rather than dismissal as secondary symptoms.
Rakesh Jain, MD, MPH, Co-Chair, Psych Congress discusses why sleep complaints in psychiatric practice warrant direct evaluation rather than dismissal as secondary symptoms.
Psych Congress Elevate Co-Chair Kristian Dambrino, DNP, PMHNP-BC, discusses practical considerations for pinpointing whether and when to begin targeted treatment for tardive dyskinesia (TD).
Psych Congress Elevate Co-Chair Kristian Dambrino, DNP, PMHNP-BC, discusses practical considerations for pinpointing whether and when to begin targeted treatment for tardive dyskinesia (TD).
Psych Congress Elevate Co-Chair Kristian Dambrino, DNP, PMHNP-BC, discusses practical considerations for pinpointing whether and when to begin targeted treatment for tardive dyskinesia (TD).
Psych Congress Elevate Co-Chair Kristian Dambrino, DNP, PMHNP-BC, discusses practical considerations for pinpointing whether and when to begin targeted treatment for tardive dyskinesia (TD).
Craig Chepke, MD, DFAPA; Kevin Williams, MS, MPAS, PA-C
Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C, discuss how busy outpatient clinicians can effectively screen for anhedonia in major depressive disorder.
Craig Chepke, MD, DFAPA, and Kevin Williams, MS, MPAS, PA-C, discuss how busy outpatient clinicians can effectively screen for anhedonia in major depressive disorder.
In this video, Craig Chepke, MD, DFAPA, Chief Medical Officer, Psych Congress, discusses the pitfalls of evaluating tardive dyskinesia (TD) treatment progress by an Abnormal Involuntary Movement Scale (AIMS) score alone.
In this video, Craig Chepke, MD, DFAPA, Chief Medical Officer, Psych Congress, discusses the pitfalls of evaluating tardive dyskinesia (TD) treatment progress by an Abnormal Involuntary Movement Scale (AIMS) score alone.
Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN
Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
